Targeted protein degradation in drug development: Recent advances and future challenges

J Song, M Hu, J Zhou, S Xie, T Li, Y Li - European Journal of Medicinal …, 2023 - Elsevier
Targeted protein degradation (TPD) has emerged as a promising therapeutic approach with
potential advantages over traditional occupancy-based inhibitors in terms of dosing, side …

Click chemistry and targeted degradation: a winning combination for medicinal chemists?

A Pasieka, E Diamanti, E Uliassi… - …, 2023 - Wiley Online Library
Click chemistry is universally recognized as a powerful strategy for the fast and precise
assembly of diverse building blocks. Targeted Protein Degradation (TPD) is a new …

The application of nanoparticles based on ferroptosis in cancer therapy

Y Li, C Wei, J Yan, F Li, B Chen, Y Sun, K Luo… - Journal of Materials …, 2024 - pubs.rsc.org
Ferroptosis is a new form of non-apoptotic programmed cell death. Due to its effectiveness in
cancer treatment, there are increasing studies on the application of nanoparticles based on …

Click chemistry in the development of PROTACs

C Yang, R Tripathi, B Wang - RSC Chemical Biology, 2024 - pubs.rsc.org
Proteolysis-targeting chimeras or PROTACs are hetero-bifunctional molecules designed to
mediate the disposal of a target protein via recruitment of the ubiquitination–proteasome …

Delivering on Cell‐Selective Protein Degradation Using Chemically Tailored PROTACs

R Yao, T Luo, M Wang - ChemBioChem, 2023 - Wiley Online Library
Abstract PROTACs (Proteolysis‐Targeting Chimeras) have emerged as a groundbreaking
class of chemical tools that facilitate the degradation of target proteins by leveraging the …

Recent Advances in Optically Controlled PROTAC

M Ouyang, Y Feng, H Chen, Y Liu, C Tan, Y Tan - Bioengineering, 2023 - mdpi.com
Proteolysis-targeting chimera (PROTAC) technology is a groundbreaking therapeutic
approach with significant clinical potential for degrading disease-inducing proteins within …

Diverse Approaches for the Difunctionalization of PPH Dendrimers, Precise Versus Stochastic: How Does this Influence Catalytic Performance?

M Petriccone, R Laurent, AM Caminade… - ACS Macro …, 2024 - ACS Publications
Random difunctionalization of dendrimer surfaces, frequently employed in biological
applications, provides the advantage of dual functional groups through a synthetic pathway …

[HTML][HTML] Characteristic roadmap of linker governs the rational design of PROTACs

Y Dong, T Ma, T Xu, Z Feng, Y Li, L Song, X Yao… - … Pharmaceutica Sinica B, 2024 - Elsevier
Proteolysis targeting chimera (PROTAC) technology represents a groundbreaking
development in drug discovery, leveraging the ubiquitin‒proteasome system to specifically …

Versatile Split-and-Mix Liposome PROTAC Platform for Efficient Degradation of Target Protein In Vivo

C Song, Z Jiao, Z Hou, Y Xing, X Sha, Y Wang, J Chen… - JACS Au, 2024 - ACS Publications
PROTAC (Proteolysis TArgeting Chimeras) is a promising therapeutic approach for targeted
protein degradation that recruits an E3 ubiquitin ligase to a specific protein of interest (POI) …

“Cicada Out of the Shell” Deep Penetration and Blockage of the HSP90 Pathway by ROS‐Responsive Supramolecular Gels to Augment Trimodal Synergistic Therapy

F Li, J Yan, C Wei, Y Zhao, X Tang, L Xu… - Advanced …, 2024 - Wiley Online Library
Deep penetration and downregulation of heat shock protein (HSP) expression in multimodal
synergistic therapy are promising approaches for curing cancer in clinical trials. However …